Stock-Based Compensation (Details Textual) - USD ($)				3 Months Ended		6 Months Ended	9 Months Ended
	Jul. 02, 2020	Jan. 10, 2020	Oct. 03, 2014	Sep. 30, 2020	Mar. 31, 2020	Jun. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Aug. 08, 2020	Jul. 29, 2020	Jul. 23, 2020	Jul. 10, 2020	Jan. 09, 2020	Dec. 31, 2019	Aug. 10, 2017
Stock Based Compensation (Textual)
Shares available for issuance													2,627,533
Common stock, shares authorized				100,000,000			100,000,000							100,000,000
Common stock, shares issued				10,521,840			10,521,840							2,627,533
Unamortized value of RSUs							$ 10,151,722
Weighted average grant date fair value								$ 6.71
Weighted average remaining amortization period							3 years 1 month 13 days
Stock Option [Member]
Stock Based Compensation (Textual)
Grant date fair value				$ 20.93			$ 20.93							$ 7.29
Dr. Braunstein's [Member] | Stock Option [Member]
Stock Based Compensation (Textual)
Incremental value				$ 500,563
Restricted Stock Units (RSUs) [Member]
Stock Based Compensation (Textual)
Common stock, shares issued									5,687	9,938		5,245
Grant date fair value				$ 29.96			$ 29.96
Unamortized value of RSUs							$ 7,604,720
Number of RSUs							104,271	0
Weighted average remaining amortization period							1 year 11 months 15 days
Grant date fair value											$ 161,246
Vested shares											5,687
Amount of charges				$ 151,843
Restricted Stock Units (RSUs) [Member] | Directors One [Member]
Stock Based Compensation (Textual)
Issuance of common stock		$ 254,000
Vested options, percentage		12.50%
Grant date fair value		$ 7,620,000
Restricted Stock Units (RSUs) [Member] | Directors Two [Member]
Stock Based Compensation (Textual)
Issuance of common stock		$ 62,000
Vested options, percentage		50.00%
Grant date fair value		$ 1,860,000
Restricted Stock Units (RSUs) [Member] | Officers [Member]
Stock Based Compensation (Textual)
Issuance of common stock		$ 91,000
Grant date fair value		$ 2,730,000
Restricted Stock Units (RSUs) [Member] | Employees [Member]
Stock Based Compensation (Textual)
Issuance of common stock		$ 14,825
Grant date fair value		$ 444,750
Restricted Stock Units (RSUs) [Member] | CEO [Member]
Stock Based Compensation (Textual)
Issuance of common stock		$ 50,000
Grant date fair value		$ 1,500,000
2020 Inducement Plan [Member]
Stock Based Compensation (Textual)
Issuance of common stock							$ 600,000
Shares available for issuance				507,350			507,350
2017 Equity Incentive Plan [Member]
Stock Based Compensation (Textual)
Shares available for issuance															2,000,000
2014 Equity Incentive Plan [Member]
Stock Based Compensation (Textual)
Shares available for issuance				232,850			232,850
Sale of stock, description							The number of shares available for issuance under the Amended 2014 Plan increased by 900,002 shares from 148,298 shares to 1,048,300 shares on January 1, 2020.
2014 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
Stock Based Compensation (Textual)
Issuance of common stock	$ 7,500
Sale of stock, description					The first quarter of 2020, the Board of Directors granted stock options to purchase an aggregate of 205,250 shares of the Company's Common Stock. These options had an exercise price ranging from $30.00 to $37.30. The options expire ten years from their respective dates of grant and vest 25% on the one year anniversary of the grant date and the remainder of the underlying shares vest in thirty-six equal monthly installments thereafter. The grant date fair value of these options was $5,453,691.	The second quarter of 2020, the Board of Directors granted stock options to purchase an aggregate of 113,450 shares of the Company's Common Stock. These options had an exercise price ranging from $24.02 to $51.12. The options expire ten years from their respective dates of grant. Options representing the purchase of 59,450 shares of the Company's Common Stock vest 25% on the one year anniversary of the date of grant and the remainder of the underlying shares vest in thirty-six equal monthly installments thereafter. Options representing the purchase of 54,000 shares of the Company's Common Stock vest monthly over one year. The grant date fair value of these options was $2,547,829.	The third quarter of 2020, the Board of Directors granted stock options to purchase an aggregate of 194,700 shares of the Company's Common Stock. These options had an exercise price ranging from $20.51 to $28.20. The options expire ten years from their respective dates of grant. Options representing the purchase of 168,450 shares of the Company's Common Stock vest 25% on the one year anniversary of the date of grant and the remainder of the underlying shares vest in thirty-six equal monthly installments thereafter. Options representing the purchase of 8,250 shares of the Company's Common Stock vest monthly over one year. Options representing the purchase of 18,000 shares of the Company's Common Stock vest monthly over three years. The grant date fair value of these options was $3,922,772.
Vested options, percentage	25.00%
Grant date fair value	$ 211,500
2014 Employee Stock Purchase Plan [Member]
Stock Based Compensation (Textual)
Sale of stock, description			The number of shares increases each January 1, commencing on January 1, 2015 and ending on (and including) January 1, 2024, by an amount equal to the lesser of one percent of the outstanding shares as of the end of the immediately preceding fiscal year, 7,025 shares or any lower amount determined by the Company’s Board of Directors prior to each such January 1st.
Common stock, shares authorized			3,513	18,012			18,012
Common stock, shares issued				13,340			13,340